| Product Code: ETC7623319 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Antispasmodics Drugs Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Antispasmodics Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Antispasmodics Drugs Market - Industry Life Cycle |
3.4 Ireland Antispasmodics Drugs Market - Porter's Five Forces |
3.5 Ireland Antispasmodics Drugs Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.6 Ireland Antispasmodics Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Ireland Antispasmodics Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Ireland Antispasmodics Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Ireland Antispasmodics Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Antispasmodics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal disorders in Ireland |
4.2.2 Growing awareness about the benefits of antispasmodics drugs in managing gastrointestinal conditions |
4.2.3 Rising healthcare expenditure and improved access to healthcare services in Ireland |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and marketing |
4.3.2 Availability of alternative treatment options such as dietary changes and stress management techniques |
5 Ireland Antispasmodics Drugs Market Trends |
6 Ireland Antispasmodics Drugs Market, By Types |
6.1 Ireland Antispasmodics Drugs Market, By Drug |
6.1.1 Overview and Analysis |
6.1.2 Ireland Antispasmodics Drugs Market Revenues & Volume, By Drug, 2021- 2031F |
6.1.3 Ireland Antispasmodics Drugs Market Revenues & Volume, By Dicyclomine Hydrochloride, 2021- 2031F |
6.1.4 Ireland Antispasmodics Drugs Market Revenues & Volume, By Loperamide Hydrochloride, 2021- 2031F |
6.1.5 Ireland Antispasmodics Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Antispasmodics Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Ireland Antispasmodics Drugs Market Revenues & Volume, By Irritable Bowel Syndrome, 2021- 2031F |
6.2.3 Ireland Antispasmodics Drugs Market Revenues & Volume, By Stomach Cramps, 2021- 2031F |
6.2.4 Ireland Antispasmodics Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Antispasmodics Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Antispasmodics Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Ireland Antispasmodics Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Ireland Antispasmodics Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Antispasmodics Drugs Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Antispasmodics Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Ireland Antispasmodics Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Ireland Antispasmodics Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Ireland Antispasmodics Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Antispasmodics Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Ireland Antispasmodics Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Ireland Antispasmodics Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Ireland Antispasmodics Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Ireland Antispasmodics Drugs Market Import-Export Trade Statistics |
7.1 Ireland Antispasmodics Drugs Market Export to Major Countries |
7.2 Ireland Antispasmodics Drugs Market Imports from Major Countries |
8 Ireland Antispasmodics Drugs Market Key Performance Indicators |
8.1 Number of prescriptions for antispasmodics drugs in Ireland |
8.2 Patient adherence rate to antispasmodics drug therapy |
8.3 Number of gastroenterologists prescribing antispasmodics drugs |
9 Ireland Antispasmodics Drugs Market - Opportunity Assessment |
9.1 Ireland Antispasmodics Drugs Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.2 Ireland Antispasmodics Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Ireland Antispasmodics Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Ireland Antispasmodics Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Ireland Antispasmodics Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Antispasmodics Drugs Market - Competitive Landscape |
10.1 Ireland Antispasmodics Drugs Market Revenue Share, By Companies, 2024 |
10.2 Ireland Antispasmodics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here